KITLG and chronic myelogenous leukemia, BCR-ABL1 positive: BM cells from CML and normal mice were transplanted into lethally irradiated mice, and after 8 weeks mice were treated with nilotinib, SCF, or a combination of nilotinib and SCF for 2 weeks (Figure 7D).